Nitrosamine related product recalls and risk assessments

Following the discovery in 2018 of N-nitrosodimethylamine (NDMA), a potential human carcinogen, in a number of Sartan drug formulations, the same nitrosamine has now been detected in batches of Zantac® and other related generic Ranitidine products.

 

Download our fact sheet to find out more about:

  • Background
  • Nitrosamine impurity analysis
  • Quality accreditation
  • Nitrosamine reference standards
  • Related services

 

 

LGC Nitrosamine Impurities fact sheet

 

 

 

LGC Download

 

 

You may also be interested in the following fact sheets:

 

LGC Materials science fact sheet        LGC Foreign particulate matter fact sheet        LGC ICH Q3D elemental impurities testing fact sheet       LGC Biopharmaceutical residual process impurities fact sheet        LGC Structural elucidation fact sheet        LGC Extractables and leachables fact sheet